1006 The anti-IGF-IR antibody figitumumab (CP-751,871) is...

1006 The anti-IGF-IR antibody figitumumab (CP-751,871) is active in patients with lung adenocarcinoma undergoing epithelial-tomesenchymal transition

A. Gualberto, M.L. Hixon, M.P. Dolled-Filhart, J. Chistensen, D.L. Rimm, A.V. Lee, Y.F. Wang, M. Pollak, L.G. Paz-Ares, D.D. Karp
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)70299-x
File:
PDF, 68 KB
english, 2009
Conversion to is in progress
Conversion to is failed